Lantheus Holdings, Inc.LNTHEarnings & Financial Report
Nasdaq · Health Care · In Vitro & In Vivo Diagnostic Substances
Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 12.60% | 8.6M | — | 2024-01-23 |
| The Vanguard Group | 10.18% | 7.0M | — | 2024-02-13 |
| S.S. OR | 5.20% | 3.6M | ▼ -0.60pp | 2024-11-14 |
| Farallon Capital Partners, L.P. | 0.50% | 367.4K | — | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-05 | Morgan Amanda Michelle | Chief Commercial Officer | Grant | 26.2K | $0.00 | $0 |
| 2026-03-05 | Daniel Niedzwiecki | See Remarks | Grant | 36.7K | $0.00 | $0 |
| 2026-03-05 | Ludger Dinkelborg | See Remarks | Grant | 21.0K | $0.00 | $0 |
| 2026-03-05 | Kimberly Brown | Chief Accounting Officer | Grant | 6.2K | $0.00 | $0 |
| 2026-03-05 | Marshall Robert J. Jr. | CFO and Treasurer | Grant | 38.0K | $0.00 | $0 |
| 2026-03-02 | Daniel Niedzwiecki | See Remarks | Grant | 5.2K | $0.00 | $0 |
| 2026-03-02 | Heino Mary Anne | Executive Chair and CEO | Grant | 32.1K | $0.00 | $0 |
| 2026-03-02 | Marshall Robert J. Jr. | CFO and Treasurer | Grant | 8.5K | $0.00 | $0 |
| 2026-03-02 | Morgan Amanda Michelle | Chief Commercial Officer | Grant | 2.8K | $0.00 | $0 |
1–9 of 9